Brieflist

NFRP Outreach and Invitation for Response

Forecast: not open for applications yet. Dates are the funder's estimate. Save a search and Brieflist marks it when it opens (Grants Pro e-mails you), or get the free weekly digest:

This is a forecast: the funder has announced the grant but applications are not open yet. Dates may change.

The Congressionally Directed Medical Research Program (CDMRP) Neurofibromatosis Research Program (NFRP) and the US Army Medical Research Acquisition Activity (USAMRAA) are exploring the possibility of pursuing a Research-based Other Transactions Agreement …

Read the official page on Grants.gov ↗ Get new grants like this

Funder
Defense Health Agency Contracting Activity - DHACA (Department of Defense)
Where
🇺🇸 United States
Status
Forecast
Funding
Not stated
Who can apply
Most organisations
Topics
Science & research
Opportunity number
W81XWH-21-NFRP-OUTREACH
Instrument
Other
Cost sharing
Required

About this grant

The Congressionally Directed Medical Research Program (CDMRP) Neurofibromatosis Research Program (NFRP) and the US Army Medical Research Acquisition Activity (USAMRAA) are exploring the possibility of pursuing a Research-based Other Transactions Agreement (rOTA) in accordance with 10 U.S.C. 2371 to support a major goal/product-driven team of exceptional institutions and investigators that will accelerate the clinical translation of basic NF research and ultimately decrease the impact of the disease. The objectives of the resulting rOTA shall be to conceive, design, develop, and conduct collaborative Phase I and II clinical evaluations of promising therapeutic agents for the management or treatment of NF1, NF2, and schwannomatosis. Historically, this requirement has been competed as an assistance agreement, with prior awards made as part of the FY06, FY11, and FY16 portfolios. If the Government pursues this requirement as a rOTA, it is anticipated that this will be awarded as part of the FY21 portfolio.

The Government is currently requesting feedback regarding the proposed approach and capabilities . All communication may be sent to [email protected] . This Outreach and Invitation for Response is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offers will be considered. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding accordingly.

General Information

The Government anticipates an arrangement with a single Operations Center and a minimum of five Clinical Trial Sites with a demonstrated history of collaborative research. The participants will be jointly responsible for prioritizing, proposing, conducting, and analyzing Phase I and Phase II clinical trials focused on therapeutic interventions for NF1, NF2, and schwannomatosis.

The Government is open to discussions regarding teaming arrangements or consortiums.

K ey Features:

Cost Sharing - Research OTA’s require cost sharing, with Government funds not to exceed the total amount provided by other parties to the maximum extent practicable. Any resulting requirement will include a requirement for cost-sharing, and offerors will be required to demonstrate how resources (e.g. cash and non-cash) will be made available for this project. Please also note that the Government’s funds shall not be front-loaded, with certain matches being required before additional Government funds are made available.

Industry Partner- Any resulting proposal request may include a requirement to partner with a for-profit company. A letter of commitment may be required as part of any resulting proposal.

Milestone Based Payments- It is anticipated that milestone based payments will be included in this project.

Technical/ Data Rights- The Government intends to negotiate technical/ data rights as needed.

Access to populations- Given that this rOTA will sponsor Phase I and II clinical trials, any resulting proposal will include demonstrated access to patient populations.

Eligibility

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Applying for grants? Grants Pro e-mails you every morning with the new grants and opened forecasts that match your saved searches, and adds deadline reminders in your calendar, a private RSS feed and CSV export. Try it free for 7 days, then $9/month, cancel any time. See what Pro does →

Applying? Read how to write a winning grant proposal.

Data from Grants.gov, US federal government (public domain). Last checked 19 Nov 2026. Always read the official page before applying: it has the full conditions, documents and how to apply.

Similar grants